A Controlled Study of Biopsychosocial Differences Observed in Masticatory Myalgia With and Without Pain Referral

Aims: To assess differences in biopsychosocial factors between participants with masticatory myofascial pain with referral (MFPwR), with myalgia without referral (Mw/oR), and community controls without TMDs. Methods: Study participants were diagnosed with MFPwR (n = 196), Mw/oR (n = 299), or as a non-TMD community control (n = 87) by two calibrated examiners at each of three study sites. Pain chronicity, pain on palpation of masticatory muscle sites, and pressure pain thresholds (PPT) at 12 masticatory muscle, 2 trigeminal, and 2 nontrigeminal control sites were recorded. Psychosocial factors assessed included anxiety, depression, and nonspecific physical symptoms (Symptom Checklist-90 Revised); stress (Perceived Stress Scale); and health-related quality of life (Short Form Health Survey). Comparisons among the three groups were adjusted for age, sex, race, education, and income using multivariable linear regression. The significance threshold was set at P = .017 (.05 / 3) for subsequent pairwise comparisons. Results: Compared to the Mw/oR group, the MFPwR group had significantly greater pain chronicity, number of painful muscle sites, anxiety, depression, nonspecific physical symptoms, and impaired physical health (P < .017). The MFPwR group also had significantly lower PPTs for masticatory sites (P < .017). Both muscle pain groups differed significantly from the non-TMD community control group for all outcome measures (P < .017). Conclusion: These findings support the clinical utility of separating MFPwR from Mw/oR. Patients with MFPwR are more complex from a biopsychosocial perspective than Mw/oR patients, which likely affects prognosis and supports consideration of these factors in case management.

biopsychosocial; diagnosis; myofascial; pain; pain referral; temporomandibular disorders

1. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997;8:291–305.

2. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

3. Schiffman EL, Truelove EL, Ohrbach R, et al. The research diagnostic criteria for temporomandibular disorders. I: Overview and methodology for assessment of validity. J Orofac Pain 2010;24:7–24.

4. Michelotti A, Alstergren P, Goulet JP, et al. Next steps in development of the diagnostic criteria for temporomandibular disorders (DC/TMD): Recommendations from the International RDC/TMD Consortium Network workshop. J Oral Rehabil 2016;43:453–467.

5. Bossuyt PMM, Reitsma JB, Linnet K, Moons KGM. Beyond diagnostic accuracy: The clinical utility of diagnostic tests. Clin Chem 2012;58:1636–1643.

6. Barjandi G, Kosek E, Hedenberg-Magnusson B, Velly AM, Ernberg M. Cobmorbid conditions in temporomandibular di-orders myalgia and myofascial pain compared to fibromyalgia. J Clin Med 2021;10:3138.

7. Lövgren A, Visscher CM, Lobbezoo F, et al. The association of myofascial orofacial pain with and without referral and wide spread pain. Acta Odontol Scand 2022;80:481–486.

8. Winocur-Arias O, Friedman-Rubin P, Abu Ras K, et al. Local myalgia compared to myofascial pain with referral according to the DC/TMD: Axis I and II results. BMC Oral Health 2022;22:27.

9. von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg 2014;12:1495–1499.

10. Ohrbach R, Gonzalez Y, List T, Michelotti A, Schiffman E. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Clinical Examination Protocol. Version: January 6, 2014. Accessed 26 May 2023. https://ubwp.buffalo.edu/rdc-tmdin-ternational/wp-content/uploads/sites/58/2017/01/DC-TMD-Protocol-2013_06_02.pdf

11. Derogatis LR. SCL-90R: Administration, Scoring and Procedures Manual II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series. Clinical Psychometric Research, 1986.

12. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

13. Dworkin SF, Sherman J, Mancl L, et al. Reliability, validity, and clinical utility of the research diagnostic criteria for temporo-mandibular disorders axis II scales: Depression, nonspecific physical symptoms, and graded chronic pain. J Orofac Pain 2002;16:207–220.

14. Anderson GC, Gonzalez YM, Ohrbach R, et al. The research diagnostic criteria for temporomandibular disorders. VI: Future directions. J Orofac Pain 2010;24:79–88.

15. Velly AM, Gornitsky M, Philippe P. Contributing factors to chronic myofascial pain: A case-control study. Pain 2003;104:491–499.

16. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.

17. Taylor JM. Psychometric analysis of the ten-item perceived stress scale. Psychol Assess 2015;27:90–101.

18. Roberti JW, Harrington LN, Storch EA. Further psychometric support for the 10-item version of the Perceived Stress Scale. J Coll Couns 2006;9:135–147.

19. Lee E-H. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res (Korean Soc Nurs Sci) 2012;6:121–127.

20. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–233.

21. Luo X, George ML, Kakouras I, et al. Reliability, validity, and responsiveness of the short form 12-item survey (SF-12) in patients with back pain. Spine (Phila Pa 1976) 2003;28:1739–1745.

22. Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am 2013;57:465–479.

23. Rammelsberg P, LeResche L, Dworkin S, Mancl L. Longitudinal outcome of temporomandibular disorders: A 5-year epidemio-logic study of muscle disorders defined by the research diagnostic criteria for temporomandibular disorders. J Orofac Pain 2003;17:9–20.

24. Carlson CR, Reid KI, Curran SL, et al. Psychological and physiological parameters of masticatory muscle pain. Pain 1998;76:297–307.

25. Svensson P, List T, Hector G. Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001;92:399–409.

26. Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: Evidence for altered temporal summation of pain. Pain 1998;76:71–81.

27. Greenspan JD, Slade GD, Bair E, et al. Pain sensitivity risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case control study. J Pain 2011;12(11 suppl):T61–T74.

28. Sarlani E, Greenspan JD. Evidence for generalized hyperalgesia in temporomandibular disorders patients. Pain 2003;102:221–226.

29. Sarlani E, Grace EG, Reynolds MA, Greenspan JD. Evidence for up-regulated central nociceptive processing in patients with masticatory myofascial pain. J Orofac Pain 2004;18:41–55.

30. Kashima K, Rahman OI, Sakoda S, Shiba R. Increased pain sensitivity of the upper extremities of TMD patients with myalgia to experimentally-evoked noxious stimulation: Possibility of worsened endogenous opioid systems. Cranio 1999;17:241–246.

31. Velly AM, Look JO, Carlson C, et al. The effect of catastrophizing and depression on chronic pain—A prospective cohort study of temporomandibular muscle and joint pain disorders. Pain 2011;152:2377–2383.

32. Sherman JJ, LeResche L, Huggins KH, Mancl LA, Sage JC, Dworkin SF. The relationship of somatization and depression to experimental pain response in women with temporomandibular disorders. Psychosom Med 2004;66:852–860.

33. Macfarlane TV, Gray RJM, Kincey J, Worthington HV. Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study. Oral Dis 2001;7:321–330.

34. Kight M, Gatchel RJ, Wesley L. Temporomandibular disorders: Evidence for significant overlap with psychopathology. Health Psychol 1999;18:177–182.

35. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(11 suppl):T46–T60.

36. Beaton RD, Egan KJ, Nakagawa-Kogan H, Morrison KN. Self-reported symptoms of stress with temporomandibular disorders: Comparisons to healthy men and women. J Prosthet Dent 1991;65:289–293.

37. Mas´lak-Beres´ M, Loster JE, Wieczorek A, Loster BW. Evaluation of the psychoemotional status of young adults with symptoms of temporomandibular disorders. Brain Behav 2019;9:e01443.

38. Slade GD, Diatchenko L, Bhalang K, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res 2007;86:1120–1125.

39. Collado-Mateo D, Chen G, Garcia-Gordillo MA, et al. Fibromyalgia and quality of life: Mapping the revised fibromyal-gia impact questionnaire to the preference-based instruments. Health Qual Life Outcomes 2017;15:114.

40. List T, John MT, Ohrbach R, Schiffman EL, Truelove EL, Anderson GC. Influence of temple headache frequency on physical functioning and emotional functioning in subjects with temporoman-dibular disorder pain. J Orofac Pain 2012;26:83–90.

41. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: A population-based case-control study. Neurology 2000;55:629–635.

42. Manfredini D, Winocur E, Ahlberg J, Guarda-Nardini L, Lobbezoo F. Psychosocial impairment in temporomandibular disorders patients. RDC/TMD axis II findings from a multicentre study. J Dent 2010;38:765–772.